Ann: Stage 2 of Clinical Trial Activated, page-30

Interesting commentary from a large global medical market research company - headquartered in India with offices in USA. We are definitely being watched with a great deal of interest. Note the last paragraph - we are on the cusp of that opportunity wave!

EMVision Initiated the Stage II of the Portable Brain Scanner Trial

On May 30, 2023, the Australia-based EMVision Medical Devices initiated the Stage II of its clinical trial for its first-generation portable brain scanner.

The first phase of the trial has just recently been completed, involving 30 healthy volunteers.

Further, 150 patients with acute strokes and stroke mimics are expected to enroll in the second stage. Major comprehensive stroke centers in Australia, including Royal Melbourne Hospital, Princess Alexandra Hospital, and Liverpool Hospital, are participating in the trial.

Each site has a population of stroke patients and a committed research team to support a quick patient enrolment process.

EMVision Medical Devices CEO Dr. Ron Weinberger said, “Significant preparation and positive collaboration between the EMVision team and hospital staff has been underway to ensure the next phase of our multi-site clinical trials is set up for success. We have taken the technical and usability information from Stage I and refined our device for Stage II and although the modifications are not major, they will result in significant performance improvements.”

According to DelveInsight’s “Neurology Devices Market” report, the global neurology devices market is estimated to grow at a CAGR of 7.46% during the forecast period from 2023 to 2028.

The neurology devices market is observing optimistic market growth due to factors such as the rise in the number of regulatory approvals for neurology devices across the globe. Further, the increasing cases of head injuries owing to accidents, workplace injuries, and others, and the rise in the geriatric population coupled with the increasing prevalence of neurological diseases are going to increase the demand for various neurological devices across the globe.

Additionally, the growing focus on improving the safety, affordability, and usability of neurology devices for end users is further expected to result in appreciable revenue growth in the neurology devices market during the forecast period (2023-2028).

https://www.delveinsight.com/blog/medtech-news-for-cepheid-anika-emvision